Ivan Bozin

6PUBLICATIONS
29CO-AUTHORS
Medical infection agents (incl. prions)Medical parasitologyMedical virologyGeriatrics and gerontologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 18, 2026
Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.

Ahmed Z Obeidat, Michelle Betz, Rebecca Straus Farber

|Sep 12, 2025
Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis.

Carrie M Hersh, Yolanda Aladro-Benito, James B Lewin

|Dec 14, 2024
Long-Term Safety and Effectiveness of Dimethyl Fumarate in Patients with Multiple Sclerosis Treated in Routine Medical Practice: Final Analysis of the ESTEEM Study.

Krupa Shah Pandey, Kathryn Giles, Konstantin Balashov

|Nov 21, 2024
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.

Yang Mao-Draayer, Amit Bar-Or, Konstantin Balashov

|Aug 19, 2024
Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons.

Tammy Jiang, Mathura Shanmugasundaram, Ivan Božin

|Jun 15, 2024
Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study.

James D Bowen, Jessica Stulc, Samuel F Hunter

Pageof 1

Frequent Collaborators

5 joint publications

James B Lewin

2 joint publications

Yang Mao-Draayer

2 joint publications

Zhaonan Sun

2 joint publications

Jason P Mendoza